HomeAI · summaries
Storia in 3 fonti
Oxford University and Moderna launch trials of vaccine that could prevent cancer
The jab targets patients with Lynch syndrome, who are at high risk of bowel and ovarian cancer
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
independent.co.uk
Oxford University and Moderna launch trials of vaccine that could prevent cancer
The jab targets patients with Lynch syndrome, who are at high risk of bowel and ovarian cancer
- ·
morningstar.com
Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People…
Lynch syndrome is an inherited condition affecting 1 in 300 people that causes lifetime cancer risk of up to 80%[1]The INTERCEPT-Lynch trial is part of a scientific collaboration…
- ·
Oxford University and Moderna to trial pioneering cancer vaccine
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…
- ·
dailymail.com
'Prevention vaccine' for bowel and ovarian cancer developed
A revolutionary vaccine that could prevent cancer for people at high risk of bowel and ovarian cancer has been developed.